about
Mitochondrial acetylome analysis in a mouse model of alcohol-induced liver injury utilizing SIRT3 knockout miceAn Update on Inflamm-Aging: Mechanisms, Prevention, and TreatmentProtective effects and mechanisms of sirtuins in the nervous systemTargeting heat shock proteins to modulate α-synuclein toxicityDisruptive chemicals, senescence and immortalityMitochondrial function in hypoxic ischemic injury and influence of agingResveratrol improves cardiac contractility following trauma-hemorrhage by modulating Sirt1Rejuvenating sirtuins: the rise of a new family of cancer drug targetsPathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.The class III histone deacetylase sirtuin 1 in immune suppression and its therapeutic potential in rheumatoid arthritis.The Synergistic Role of Light-Feeding Phase Relations on Entraining Robust Circadian Rhythms in the Periphery.Complete NMR data of methoxylated cis- and trans-stilbenes as well as 1,2-diphenylethanes.The ways and means that fine tune Sirt1 activity.Polyphenols and aging.Resveratrol, a red wine constituent, blocks the antimitogenic effects of estradiol on human female coronary artery smooth muscle cells.SIRT1 and p53, effect on cancer, senescence and beyond.Energy restriction and potential energy restriction mimetics.SirT1 brings stemness closer to cancer and aging.4-Hydroxynonenal inhibits SIRT3 via thiol-specific modification.Fibroblast growth factor-21 enhances mitochondrial functions and increases the activity of PGC-1α in human dopaminergic neurons via Sirtuin-1.Tetrahydrocurcumin extends life span and inhibits the oxidative stress response by regulating the FOXO forkhead transcription factor.Sirtuin 1: A Target for Kidney Diseases.Pleiotropic protective effects of phytochemicals in Alzheimer's diseaseAging, metabolic syndrome and the heart.Cerebral Perfusion Enhancing Interventions: A New Strategy for the Prevention of Alzheimer Dementia.Contribution of mitochondrial oxidative stress to hypertension.Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer.SIRT1: Regulator of p53 DeacetylationAlternate strategies of Hsp90 modulation for the treatment of cancer and other diseases.Does autophagy take a front seat in lifespan extension?HDAC inhibitors in parasitic diseases.A patent review of sirtuin activators: an update.Telomeres and disease: enter TERRA.Epigenetic mechanisms in learned fear: implications for PTSD.Sirtuin activators and inhibitors.Sirtuins in dermatology: applications for future research and therapeutics.Epigenetic effects of natural polyphenols: a focus on SIRT1-mediated mechanisms.Melatonin and the theories of aging: a critical appraisal of melatonin's role in antiaging mechanisms.Role of SIRT1 in autoimmune demyelination and neurodegeneration.Anticancer agents targeted to sirtuins.
P2860
Q24597912-15A526D0-FFC4-4A5A-A505-743E3A368A5AQ26738759-3E6D6756-A0FD-4560-A5CA-EF207C311506Q26825585-EE3EAB46-E129-4412-93C5-6828E274183EQ26827066-83DF2D92-E199-419E-83E9-E133B3C2E5FEQ27026235-75B8AD61-92BD-4F67-B98E-626A91CEF36CQ28396663-8E57EAAB-5BF0-49C8-855F-10A95C3D7197Q28567865-1D7BEB98-BC7D-4ECB-A69B-DE603E78AC37Q30570951-C8DEEC58-5C34-4BD8-87EF-C26692E3FA01Q30597265-D4D90E33-9A9B-43D6-8063-E7A1B6F92280Q33554869-36928473-7B4B-4A20-98FB-5FBD1F4E2758Q33602912-11789B86-47AF-48A1-8C55-31019BC64F2BQ33858492-4E9A9555-2CA2-4144-9593-CBC8A0FEB21BQ33914710-F374CF29-96B1-438B-BE67-38F8D3E65AEFQ33957220-A4E44814-B9ED-4F30-9801-F9AEF968C677Q34113185-406F7D30-B79F-4E0F-83F9-F9A9F2028A73Q34341091-3F8AF115-CE7E-45D0-AF02-C3F2C515AA7AQ34495145-BEC58273-3E3E-423A-8878-1BCDF5F6448FQ34852306-2630BF78-31B4-429B-9380-5C15E2550CA6Q35041432-8F203A43-0703-4C5F-91B6-EBECC77483FCQ35537540-FDD7F875-3FCF-47C5-A53D-4BBA9701B507Q35645159-A2462CBE-4AFF-4B1C-AE31-FAE3AB49C884Q35707150-264733E2-26FF-45BC-9F9F-19C0C5664873Q36012073-24285142-9711-46DB-9B8F-5ECC1C6610F4Q36031750-2B406F92-6965-42E0-B28C-8562F91AE5CCQ36057329-BDCAA35A-1D75-41EA-BA1D-B1175DB5350AQ36617393-BBC3B4D0-C4F9-4070-B593-9AD6538210F2Q36809695-1E8B3E23-AB09-4D82-8D62-3DEA42EFB7F7Q37150526-81477719-2043-4A99-A0D6-17799B5631E8Q37622446-2045E0AB-4084-4949-84B1-0834D9C30250Q37813188-E4C14693-0CFC-43EE-9E5D-084F2FF17224Q37962336-170E63F3-E545-45E9-BAF3-C172C5563CCDQ37999924-066A0FFA-0E92-4668-B902-41915EF9A866Q38012331-E0799A62-1401-48B4-97F4-2575E884B71FQ38018260-D2F10DCC-790A-4FCB-B5B3-C81A6B67CAFFQ38021431-B3E8624D-EE00-4C1A-9496-7361808BB3F5Q38078763-67549D57-2B8E-4908-A385-A64C00B7A8F2Q38123766-24A9FC2B-D0F7-49AA-A446-C67E4D3BE0CBQ38151200-D4B09A9B-B56C-438A-89A9-0C202F0BBE5AQ38256576-31EF3087-BAA5-48E7-A786-F05727651A3AQ38285137-444ECD1B-A85F-4813-9E22-58E3C874F6B8
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Sirtuin activators
@ast
Sirtuin activators
@en
Sirtuin activators
@nl
type
label
Sirtuin activators
@ast
Sirtuin activators
@en
Sirtuin activators
@nl
prefLabel
Sirtuin activators
@ast
Sirtuin activators
@en
Sirtuin activators
@nl
P3181
P1476
Sirtuin activators
@en
P2093
Francisco J Alcaín
José M Villalba
P304
P3181
P356
10.1517/13543770902762893
P407
P577
2009-04-01T00:00:00Z